A group of German chemistry professors sent a letter to the Paul Ehrlich Institute (PEI), writing that “the problems with modRNA-based vaccines are becoming increasingly apparent.”
The letter was obtained by the Berliner Zeitung.
The scientists cited a study from the journal Nature, where unwanted proteins were discovered in patients who received an mRNA inoculation.
Undesired proteins could “contribute to the toxicity of the modRNA injections, which needs to be clarified in further studies,” according to a commentary on the study’s findings, as recorded in the German outlet.
The German scientists asked PEI, “When did you become aware of this work and the problem of the ribosomal shift in modRNA-based injections? Why wasn’t this obvious problem recognized earlier? What investigations are planned by the PEI to investigate the toxicity of the unwanted proteins and what steps are planned by the PEI to eliminate or at least reduce such threats to modRNA technology?”
“From the PEI’s perspective, should these new findings have an impact on the approval of these new modRNA-based drugs and if so, which ones and if no, why not? How does PEI plan to inform the public about these new findings about potentially dangerous side effects of modRNA technology,” the letter asked.
American Faith previously reported that a review in the journal Biomedicines detailed that the mRNA in COVID-19 vaccines is pathogenic.
As “unprecedented high rates of adverse events” have eclipsed the idea of “safe and effective” vaccines, a group of scientists sought to “provide a thorough overview of harms arising from the new technology in vaccines that relied on human cells producing a foreign antigen that has evidence of pathogenicity,” the study reads.
The authors found several COVID-19 vaccine issues requiring analysis, namely, that the spike protein “both from the virus and also when produced by gene codes in the novel COVID-19 mRNA and adenovectorDNA vaccines” is toxic.
Upon analyzing literature providing evidence for the toxicity of the spike protein, the researchers determined that it is critical to “evaluate the potential for any new autoimmune phenomena driven by foreign antigen production caused by any new mRNA or DNA-based technology in the future.”
